{
    "pmcid": "11783119",
    "qa_pairs": {
        "How does AlphaFold-Multimer contribute to the design of SARS-CoV-2 nanobody binders?": [
            "It predicts the structural dynamics of nanobody interactions with the SARS-CoV-2 spike protein.",
            "It directly synthesizes nanobodies that bind to the SARS-CoV-2 spike protein.",
            "It identifies mutations in the SARS-CoV-2 spike protein that enhance nanobody binding.",
            "It provides empirical data on nanobody efficacy against SARS-CoV-2."
        ],
        "How does the integration of AlphaFold-Multimer with DMS enhance understanding of epitope-paratope interactions?": [
            "By providing structural insights into how mutations affect the complex.",
            "By directly measuring the binding affinity of nanobodies to the spike protein.",
            "By generating a library of nanobodies with enhanced binding properties.",
            "By predicting the immune response to SARS-CoV-2 infections."
        ],
        "What is a challenge mentioned in integrating AlphaFold-Multimer predictions with DMS data?": [
            "Validating structural predictions with empirical data to ensure functional relevance.",
            "Generating high-resolution structures of protein complexes.",
            "Predicting linear epitopes accurately.",
            "Linking genotype to phenotype in low-throughput settings."
        ],
        "What is a key advantage of deep mutational scanning (DMS) over traditional methods like X-ray crystallography in epitope mapping?": [
            "DMS offers a high-throughput approach that efficiently scans large libraries of single amino acid mutations.",
            "DMS provides higher resolution structures than X-ray crystallography.",
            "DMS is less labor-intensive than NMR but provides lower resolution.",
            "DMS can only map linear epitopes, unlike Cryo-EM which can map both linear and conformational epitopes."
        ],
        "What potential future development is anticipated to enhance the design of nanobodies according to the summary?": [
            "The development of AlphaFold 3 with improved capabilities in predicting protein complexes.",
            "The creation of a new DMS technique that maps epitopes without mutations.",
            "The invention of a novel X-ray crystallography method for high-throughput analysis.",
            "The introduction of a Cryo-EM variant that requires no sample preparation."
        ]
    }
}